{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:40:53Z","timestamp":1790343653036,"version":"4.1.0"},"reference-count":178,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008725","name":"Agencia Nacional de Investigaci\u00f3n e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008743","name":"Ministerio de Educaci\u00f3n y Cultura de Uruguay","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008743","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024018","name":"Programa de Desarrollo de las Ciencias B\u00e1sicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ibroneuroscience.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.neuroscience.2024.12.039","type":"journal-article","created":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T00:37:18Z","timestamp":1735087038000},"page":"149-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Plant-derived compounds and neurodegenerative diseases: Different mechanisms of action with therapeutic potential"],"prefix":"10.1016","volume":"566","author":[{"given":"Carolina","family":"Echeverry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Pazos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximiliano","family":"Torres-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6412-1114","authenticated-orcid":false,"given":"Giselle","family":"Prunell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.neuroscience.2024.12.039_b0005","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.3390\/antiox11101986","article-title":"Quercetin nanoemulsion ameliorates neuronal dysfunction in experimental alzheimer\u2019s disease model","volume":"11","author":"Alaqeel","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.neuroscience.2024.12.039_b0010","unstructured":"Alzheimer\u2019s Disease International World Alzheimer Report 2019: attitudes to dementia. https:\/\/www.alzint.org\/u\/WorldAlzheimerReport2019."},{"key":"10.1016\/j.neuroscience.2024.12.039_b0015","volume":"62","author":"Andres","year":"2018","journal-title":"Safety Aspects of the Use of Quercetin as a Dietary Supplement"},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.039_b0020","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jnutbio.2008.03.002","article-title":"Protective effect of quercetin in primary neurons against A\u03b2(1-42): relevance to alzheimer\u2019s disease","volume":"20","author":"Ansari","year":"2009","journal-title":"J. Nutr. Biochem."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.039_b0025","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/02791072.2020.1752960","article-title":"Personality traits in former spanish substance users recovered with ayahuasca","volume":"52","author":"Apud","year":"2020","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.neuroscience.2024.12.039_b0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-3-030-55688-4_9","article-title":"Ayahuasca as an addiction treatment in catalonia: cognitive and cultural perspectives","author":"Apud","year":"2021","journal-title":"Ayahuasca Healing and Science"},{"issue":"7","key":"10.1016\/j.neuroscience.2024.12.039_b0035","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ijdevneu.2004.07.007","article-title":"Neurodegeneration and plasticity","volume":"22","author":"Arendt","year":"2004","journal-title":"Int. J. Dev. Neurosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jep.2003.11.012","article-title":"Cytoprotection by achyrocline satureioides (Lam) D.C. and some of its main flavonoids against oxidative stress","volume":"91","author":"Arredondo","year":"2004","journal-title":"J. Ethnopharmacol."},{"issue":"5","key":"10.1016\/j.neuroscience.2024.12.039_b0045","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.freeradbiomed.2010.05.020","article-title":"After cellular internalization, quercetin causes Nrf2 nuclear translocation, increases glutathione levels, and prevents neuronal death against an oxidative insult","volume":"49","author":"Arredondo","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuroscience.2024.12.039_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102489","article-title":"The molecular activity of cannabidiol in the regulation of Nrf2 System interacting with NF-\u039aB pathway under oxidative stress","volume":"57","author":"Atalay Ekiner","year":"2022","journal-title":"Redox Biol."},{"issue":"9","key":"10.1016\/j.neuroscience.2024.12.039_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18091989","article-title":"Quercetin attenuates manganese-induced neuroinflammation by alleviating oxidative stress through regulation of apoptosis, INoS\/NF-\u039aB and HO-1\/Nrf2 pathways","volume":"18","author":"Bahar","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"APR","key":"10.1016\/j.neuroscience.2024.12.039_b0060","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fpsyt.2018.00136","article-title":"Assessment of alcohol and tobacco use disorders among religious users of ayahuasca","volume":"9","author":"Barbosa","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.12.039_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.989717","article-title":"Cannabidiol for neurodegenerative disorders. A comprehensive review","volume":"13","author":"Bhunia","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.neuroscience.2024.12.039_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2023.105537","article-title":"Achyrocline satureioides review: from the pharmacochemical diversity to the technological development of products","volume":"168","author":"Bianchi","year":"2023","journal-title":"Fitoterapia"},{"key":"10.1016\/j.neuroscience.2024.12.039_b0075","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ejphar.2008.03.008","article-title":"Health effects of quercetin: from antioxidant to nutraceutical","author":"Boots","year":"2008","journal-title":"Eur. J. Pharmacol. May 13"},{"issue":"5","key":"10.1016\/j.neuroscience.2024.12.039_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms23052514","article-title":"Impact of two neuronal sigma\u20101 receptor modulators, PRE084 and DMT, on neurogenesis and neuroinflammation in an A\u03b21\u201042\u2010injected, wild\u2010type mouse model of AD","volume":"23","author":"Borb\u00e9ly","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2024.12.039_b0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.freeradbiomed.2014.07.033","article-title":"NADPH oxidase- and mitochondria-derived reactive oxygen species in proinflammatory microglial activation: a bipartisan affair?","volume":"76","author":"Bordt","year":"2014","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0090","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrn1809","article-title":"Neural plasticity in the ageing brain","volume":"7","author":"Burke","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.039_b0095","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/pharmaceutics12030265","article-title":"Cannabinoids, blood\u2013brain barrier, and brain disposition","volume":"12","author":"Calapai","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neuroscience.2024.12.039_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/2509129","article-title":"Preclinical and clinical evidence supporting use of cannabidiol in psychiatry","volume":"2019","author":"Calapai","year":"2019","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"7","key":"10.1016\/j.neuroscience.2024.12.039_b0105","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1021\/acschemneuro.8b00692","article-title":"Chronic, intermittent microdoses of the psychedelic N, N-dimethyltryptamine (DMT) produce positive effects on mood and anxiety in rodents","volume":"10","author":"Cameron","year":"2019","journal-title":"ACS Chem. Nerosci."},{"issue":"10","key":"10.1016\/j.neuroscience.2024.12.039_b0110","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1021\/acschemneuro.8b00101","article-title":"Dark classics in chemical neuroscience: N, N-dimethyltryptamine (DMT)","volume":"9","author":"Cameron","year":"2018","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.neuroscience.2024.12.039_b0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.phrs.2016.01.033","article-title":"Cannabidiol, neuroprotection and neuropsychiatric disorders","volume":"112","author":"Campos","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"Pt 1","key":"10.1016\/j.neuroscience.2024.12.039_b0120","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainresbull.2016.04.016","article-title":"Neuropharmacology of N,N-dimethyltryptamine","volume":"126","author":"Carbonaro","year":"2016","journal-title":"Brain Res. Bull."},{"issue":"20","key":"10.1016\/j.neuroscience.2024.12.039_b0125","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1073\/pnas.0511232103","article-title":"Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression","volume":"103","author":"Carrier","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuroscience.2024.12.039_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00124","article-title":"From cannabis sativa to cannabidiol: promising therapeutic candidate for the treatment of neurodegenerative diseases","volume":"11","author":"Cassano","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"May","key":"10.1016\/j.neuroscience.2024.12.039_b0135","first-page":"1","article-title":"Neuronal cells rearrangement during aging and neurodegenerative disease: metabolism, oxidative stress and organelles dynamic","volume":"12","author":"Castelli","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.039_b0140","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrn1078","article-title":"Neurotrophins and their receptors: a convergence point for many signalling pathways","volume":"4","author":"Chao","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7812\/TPP\/19.200","article-title":"Mechanisms of action and pharmacokinetics of cannabis","volume":"25","author":"Chayasirisobhon","year":"2021","journal-title":"Perm. J."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0150","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/10799893.2015.1049363","article-title":"Protection afforded by quercetin against H 2 O 2 -induced apoptosis on PC12 cells via activating PI3K\/Akt signal pathway","volume":"36","author":"Chen","year":"2016","journal-title":"J. Recept. Signal Transduction"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0155","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s11658-023-00462-9","article-title":"The NLRP3 inflammasome: contributions to inflammation-related diseases","volume":"28","author":"Chen","year":"2023","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.neuroscience.2024.12.039_b0160","first-page":"1","article-title":"N , N \u2013 dimethyltryptamine , a natural hallucinogen , ameliorates alzheimer \u2019 s disease by restoring neuronal sigma \u2013 1 receptor \u2013 mediated endoplasmic reticulum \u2013 mitochondria crosstalk","volume":"3","author":"Cheng","year":"2024","journal-title":"Alzheimers Res. Ther."},{"issue":"7","key":"10.1016\/j.neuroscience.2024.12.039_b0165","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.3390\/ijms24076328","article-title":"The potential benefits of quercetin for brain health: a review of anti-inflammatory and neuroprotective mechanisms","volume":"24","author":"Chiang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2024.12.039_b0175","first-page":"490","article-title":"13 Reasons why the brain is susceptible to oxidative stress","author":"Cobley","year":"2018","journal-title":"Redox Biology. Elsevier b.v. May 1"},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.039_b0180","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2174\/157015908787386113","article-title":"Pharmacology and therapeutic potential of sigma1 receptor ligands","volume":"6","author":"Cobos","year":"2009","journal-title":"Curr. Neuropharmacol."},{"issue":"8","key":"10.1016\/j.neuroscience.2024.12.039_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15082052","article-title":"Therapeutic strategies aimed at improving neuroplasticity in alzheimer disease","volume":"15","author":"Colavitta","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neuroscience.2024.12.039_b0190","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.euroneuro.2020.08.010","article-title":"Sigma-1 (\u03a31) receptor activity is necessary for physiological brain plasticity in mice","volume":"39","author":"Crouzier","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuroscience.2024.12.039_b0195","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neuint.2015.07.002","article-title":"Quercetin in brain diseases: potential and limits","volume":"89","author":"Dajas","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuroscience.2024.12.039_b0200","doi-asserted-by":"crossref","unstructured":"Dajas, F., Rivera-Megret, F., Blasina, F., Arredondo, F., Abin-Carriquiry, J.A., Costa, G., Echeverry, C., Lafon, L., Heizen, H., Ferreira, M., Morquio, A., 2003. Neuroprotection by Flavonoids. Brazilian journal of medical and biological research Revista brasileira de pesquisas medicas e biologicas Sociedade Brasileira de Biofisica et al 36 (12), 1613\u20131620.","DOI":"10.1590\/S0100-879X2003001200002"},{"issue":"7","key":"10.1016\/j.neuroscience.2024.12.039_b0205","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/jn\/135.7.1718","article-title":"Tissue distribution of quercetin in rats and pigs","volume":"135","author":"de Boer","year":"2005","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bcpt.14011","article-title":"Effects of quercetin in preclinical models of parkinson\u2019s disease: a systematic review","volume":"135","author":"de Oliveira Vian","year":"2024","journal-title":"Basic Clin. Paharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1590\/1516-4446-2014-1496","article-title":"Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report","volume":"37","author":"de Os\u00f3rio","year":"2015","journal-title":"Rev. Bras. Psiquiatr."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0220","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000527335","article-title":"Cannabis sativa and cannabidiol: a therapeutic strategy for the treatment of neurodegenerative diseases?","volume":"5","author":"de Viana","year":"2022","journal-title":"Med. Cannabis Cannabinoids"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-45812-w","article-title":"Biosynthesis and extracellular concentrations of N,N-dimethyltryptamine (DMT) in mammalian brain","volume":"9","author":"Dean","year":"2019","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.neuroscience.2024.12.039_b0230","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"152","key":"10.1016\/j.neuroscience.2024.12.039_b0235","first-page":"67","article-title":"Crosstalk between receptor tyrosine kinases (RTKs) and G protein-coupled receptors (GPCR) in the brain: focus on heteroreceptor complexes and related functional neurotrophic effects","volume":"2019","author":"Di Liberto","year":"2018","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0240","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ptr.7309","article-title":"Quercetin and its derivates as antiviral potentials: a comprehensive review","volume":"36","author":"Di Petrillo","year":"2022","journal-title":"Phytother. Res."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.039_b0245","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3390\/metabo2020303","article-title":"A historical overview of natural products in drug discovery","volume":"2","author":"Dias","year":"2012","journal-title":"Metabolites"},{"key":"10.1016\/j.neuroscience.2024.12.039_b0250","unstructured":"Dobkin de Rios, M. Amazon Healer: The Life and Times of an Urban Shaman; Prism Press: Bridport, 1992."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0255","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis \u2013 a review","volume":"26","author":"Dobson","year":"2019","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0260","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1146\/annurev-pharmtox-010818-021856","article-title":"Modulating NRF2 in disease: timing is everything","volume":"59","author":"Dodson","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0265","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2807","article-title":"Ayahuasca may help to improve self-compassion and self-criticism capacities","volume":"37","author":"Dom\u00ednguez-Clav\u00e9","year":"2022","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neuroscience.2024.12.039_b0270","doi-asserted-by":"crossref","unstructured":"dos\u2010Santos\u2010Pereira, M., Guimar\u00e3es, F.S., Del\u2010Bel, E., Raisman\u2010Vozari, R., Michel, P.P., 2020. Cannabidiol prevents LPS\u2010induced microglial inflammation by inhibiting ROS\/NF\u2010\u03baB\u2010dependent signaling and glucose consumption. Glia 68 (3), 561\u2013573. DOI: 10.1002\/glia.23738.","DOI":"10.1002\/glia.23738"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0275","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1021\/acs.chemrev.3c00375","article-title":"Serotonin 2A receptor (5-HT2AR) agonists: psychedelics and non-hallucinogenic analogues as emerging antidepressants","volume":"124","author":"Duan","year":"2024","journal-title":"Chem. Rev."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.039_b0280","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1021\/acs.jmedchem.9b01404","article-title":"Identification of psychoplastogenic N, N-dimethylaminoisotryptamine (IsoDMT) analogues through structure-activity relationship studies","volume":"63","author":"Dunlap","year":"2020","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0285","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12640-014-9483-y","article-title":"Antioxidant activity, cellular bioavailability, and iron and calcium management of neuroprotective and nonneuroprotective flavones","volume":"27","author":"Echeverry","year":"2015","journal-title":"Neurotox. Res."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.039_b0290","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s12640-020-00277-y","article-title":"A comparative in vitro study of the neuroprotective effect induced by cannabidiol, cannabigerol, and their respective acid forms: relevance of the 5-HT1A receptors","volume":"39","author":"Echeverry","year":"2021","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuroscience.2024.12.039_b0295","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/B978-0-323-90036-2.00039-9","article-title":"Neuroprotection by the cannabis-related products, cannabidiol and cannabigerol, and their associated mechanisms of action","author":"Echeverry","year":"2023","journal-title":"In Medicinal Usage of Cannabis and Cannabinoids; Elsevier"},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.039_b0300","doi-asserted-by":"crossref","first-page":"e907","DOI":"10.1089\/can.2022.0289","article-title":"Neuroprotective effect of a pharmaceutical extract of cannabis with high content on CBD against rotenone in primary cerebellar granule cell cultures and the relevance of formulations","volume":"9","author":"Echeverry","year":"2024","journal-title":"Cannabis Cannabinoid Res."},{"issue":"5","key":"10.1016\/j.neuroscience.2024.12.039_b0305","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.lfs.2005.09.011","article-title":"Chemical constituents of marijuana: the complex mixture of natural cannabinoids","volume":"78","author":"ElSohly","year":"2005","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.039_b0310","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033118","article-title":"Clinical neurology and epidemiology of the major neurodegenerative diseases","volume":"10","author":"Erkkinen","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"8","key":"10.1016\/j.neuroscience.2024.12.039_b0315","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.bjp.0707337","article-title":"Cannabidiol in vivo blunts \u0392\u2010amyloid induced neuroinflammation by suppressing IL\u20101\u03b2 and INOS expression","volume":"151","author":"Esposito","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.039_b0320","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drugalcdep.2010.03.024","article-title":"Assessment of addiction severity among ritual users of ayahuasca","volume":"111","author":"F\u00e1bregas","year":"2010","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.039_b0330","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2125.2012.04341.x","article-title":"Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?","volume":"75","author":"Fern\u00e1ndez-Ruiz","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5916","key":"10.1016\/j.neuroscience.2024.12.039_b0340","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1126\/science.1166127","article-title":"The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator","volume":"323","author":"Fontanilla","year":"2009","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.039_b0345","first-page":"260","article-title":"Potential use of ayahuasca in grief therapy","volume":"79","author":"Gonz\u00e1lez","year":"2019","journal-title":"Omega (United States)"},{"issue":"5","key":"10.1016\/j.neuroscience.2024.12.039_b0350","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3390\/life12050682","article-title":"The efficacy of cannabis on multiple sclerosis-related symptoms","volume":"12","author":"Haddad","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.neuroscience.2024.12.039_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102010","article-title":"Quercetin hinders microglial activation to alleviate neurotoxicity via the interplay between NLRP3 inflammasome and mitophagy","volume":"44","author":"Han","year":"2021","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.039_b0360","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2174\/1570159X20666220411101217","article-title":"The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol","volume":"21","author":"Hartmann","year":"2023","journal-title":"Curr. Neuropharmacol."},{"issue":"16","key":"10.1016\/j.neuroscience.2024.12.039_b0365","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.3390\/nu14163310","article-title":"Quercetin Increases mitochondrial biogenesis and reduces free radicals in neuronal SH-SY5Y cells","volume":"14","author":"Ho","year":"2022","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.039_b0370","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.tins.2009.11.003","article-title":"MTOR signaling: at the crossroads of plasticity, memory and disease","volume":"33","author":"Hoeffer","year":"2010","journal-title":"Trends Neurosci"},{"issue":"19","key":"10.1016\/j.neuroscience.2024.12.039_b0375","doi-asserted-by":"crossref","first-page":"14514","DOI":"10.3390\/ijms241914514","article-title":"Current challenges and opportunities for improved cannabidiol solubility","volume":"24","author":"Hossain","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.neuroscience.2024.12.039_b0380","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"8","key":"10.1016\/j.neuroscience.2024.12.039_b0385","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1089\/ars.2016.6737","article-title":"Rapid antidepressant effect of hydrogen sulfide: evidence for activation of MTORC1-TrkB-AMPA receptor pathways","volume":"27","author":"Hou","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.neuroscience.2024.12.039_b0390","first-page":"657","article-title":"Pharmacokinetics and metabolism of the plant cannabinoids, \u03b4 9-tetrahydrocannibinol","author":"Huestis","year":"2005","journal-title":"Cannabidiol and Cannabinol"},{"issue":"9","key":"10.1016\/j.neuroscience.2024.12.039_b0395","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci8090177","article-title":"Neurodegenerative diseases: regenerative mechanisms and novel therapeutic approaches","volume":"8","author":"Hussain","year":"2018","journal-title":"Brain Sci."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.039_b0400","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","article-title":"Molecular targets of cannabidiol in neurological disorders","volume":"12","author":"Ibeas Bih","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"15","key":"10.1016\/j.neuroscience.2024.12.039_b0405","doi-asserted-by":"crossref","DOI":"10.3390\/cells11152384","article-title":"Serotonin receptor 5-HT2A regulates TrkB receptor function in heteroreceptor complexes","volume":"11","author":"Ilchibaeva","year":"2022","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.neuroscience.2024.12.039_b0415","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.pnpbp.2008.06.011","article-title":"Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by donepezil: role of sigma-1 receptors and IP3 receptors","volume":"32","author":"Ishima","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0420","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1471-4159.2003.02327.x","article-title":"Neuroprotective effect of cannabidiol, a non\u2010psychoactive component from cannabis sativa , on \u03b2\u2010amyloid\u2010induced toxicity in PC12 cells","volume":"89","author":"Iuvone","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuroscience.2024.12.039_b0425","doi-asserted-by":"crossref","unstructured":"Jaggar, M., Vaidya, V.A., 2018. 5-HT2A Receptors and BDNF regulation: implications for psychopathology. In 5-HT2A Receptors in the Central Nervous System; Guiard, B., Di Giovanni, G., Eds.; Humana Press Inc., Vol. 32, pp 395\u2013438. DOI: 10.1007\/978-3-319-70474-6_17.","DOI":"10.1007\/978-3-319-70474-6_17"},{"key":"10.1016\/j.neuroscience.2024.12.039_b0430","doi-asserted-by":"crossref","unstructured":"Javanbakht, P., Yazdi, F. R., Taghizadeh, F., Khadivi, F., Hamidabadi, H. G., Kashani, I. R., Zarini, D., Mojaverrostami, S., 2023. Quercetin as a possible complementary therapy in multiple sclerosis: anti-oxidative, anti-inflammatory and remyelination potential properties. Heliyon. Elsevier Ltd November 1, DOI: 10.1016\/j.heliyon.2023.e21741.","DOI":"10.1016\/j.heliyon.2023.e21741"},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.039_b0435","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1582-4934.2010.01010.x","article-title":"Basic mechanisms of neurodegeneration: a critical update","volume":"14","author":"Jellinger","year":"2010","journal-title":"J. Cell Mol. Med."},{"issue":"21","key":"10.1016\/j.neuroscience.2024.12.039_b0440","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.3390\/molecules25214930","article-title":"A critical review of the role of the cannabinoid compounds \u03b49-tetrahydrocannabinol (\u03949-THC) and cannabidiol (CBD) and their combination in multiple sclerosis treatment","volume":"25","author":"Jones","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.neuroscience.2024.12.039_b0445","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuro.2022.03.004","article-title":"Neuroprotective effects of catechin and quercetin in experimental parkinsonism through modulation of dopamine metabolism and expression of IL-1\u03b2, TNF-\u03b1, NF-\u039aB, I\u03baKB, and P53 genes in male wistar rats","volume":"90","author":"Josiah","year":"2022","journal-title":"Neurotoxicology"},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.039_b0450","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1515\/jbcpp-2015-0071","article-title":"Anti-inflammatory effects of the cannabidiol derivative dimethylheptyl-cannabidiol \u2013 studies in BV-2 microglia and encephalitogenic T cells","volume":"27","author":"Juknat","year":"2016","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.039_b0455","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/0748233713504810","article-title":"Neuroprotective effect of quercetin against oxidative damage and neuronal apoptosis caused by cadmium in hippocampus","volume":"32","author":"Kanter","year":"2016","journal-title":"Toxicol. Ind. Health"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0460","first-page":"1003","article-title":"Neuroinflammation Induces Neurodegeneration","volume":"1","author":"Kempuraj","year":"2016","journal-title":"Journal of Neurology, Neurosurgery and Spine"},{"issue":"13","key":"10.1016\/j.neuroscience.2024.12.039_b0465","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1021\/jf020071c","article-title":"Vitamin C equivalent antioxidant capacity (VCEAC) of phenolic phytochemicals","volume":"50","author":"Kim","year":"2002","journal-title":"J. Agric. Food Chem."},{"issue":"10","key":"10.1016\/j.neuroscience.2024.12.039_b0470","doi-asserted-by":"crossref","first-page":"75760","DOI":"10.1371\/journal.pone.0075760","article-title":"Sigma-1 receptor enhances neurite elongation of cerebellar granule neurons via TrkB signaling","volume":"8","author":"Kimura","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.neuroscience.2024.12.039_b0475","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/cdd.2010.23","article-title":"Neurodegenerative diseases: failures in brain connectivity","volume":"17","author":"Knight","year":"2010","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.039_b0480","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1074\/jbc.M109.069294","article-title":"Cannabinoids \u03949-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-\u039aB and interferon-\u03b2\/STAT proinflammatory pathways in BV-2 microglial cells","volume":"285","author":"Kozela","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"49","key":"10.1016\/j.neuroscience.2024.12.039_b0485","doi-asserted-by":"crossref","first-page":"11288","DOI":"10.1523\/JNEUROSCI.2284-05.2005","article-title":"Regulation of dendritic morphogenesis by ras-PI3K-Akt-MTOR and ras-MAPK signaling pathways","volume":"25","author":"Kumar","year":"2005","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0490","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl Neurodegener"},{"issue":"5","key":"10.1016\/j.neuroscience.2024.12.039_b0495","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/02791072.2017.1361559","article-title":"Nourishing the spirit: exploratory research on ayahuasca experiences along the continuum of recovery from eating disorders","volume":"49","author":"Lafrance","year":"2017","journal-title":"J. Psychoact. Drugs"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0500","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40035-017-0102-8","article-title":"Quercetin prevents spinal motor neuron degeneration induced by chronic excitotoxic stimulus by a sirtuin 1-dependent mechanism","volume":"6","author":"Lazo-Gomez","year":"2017","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.neuroscience.2024.12.039_b0505","article-title":"Cannabinoids and neuroinflammation: therapeutic implications","volume":"12","author":"Leonard","year":"2023","journal-title":"J. Affect. Disord. Rep."},{"issue":"6","key":"10.1016\/j.neuroscience.2024.12.039_b0510","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ddr.21567","article-title":"Activation of Nrf2 signaling by sitagliptin and quercetin combination against \u03b2-amyloid induced alzheimer\u2019s disease in rats","volume":"80","author":"Li","year":"2019","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.neuroscience.2024.12.039_b0515","first-page":"1","article-title":"Quercetin protects against MPP+\/MPTP-induced dopaminergic neuron death in parkinson\u2019s disease by inhibiting ferroptosis","volume":"2022","author":"Lin","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"6","key":"10.1016\/j.neuroscience.2024.12.039_b0520","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1021\/acs.jnatprod.0c00138","article-title":"Inhibitory effect of cannabidiol on the activation of NLRP3 inflammasome is associated with its modulation of the P2X7 receptor in human monocytes","volume":"83","author":"Liu","year":"2020","journal-title":"J. Nat. Prod."},{"issue":"5","key":"10.1016\/j.neuroscience.2024.12.039_b0525","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1021\/acs.jnatprod.1c00083","article-title":"Cannabidiol protects human skin keratinocytes from hydrogen-peroxide-induced oxidative stress via modulation of the caspase-1\u2013IL-1\u03b2 axis","volume":"84","author":"Liu","year":"2021","journal-title":"J. Nat. Prod."},{"issue":"11","key":"10.1016\/j.neuroscience.2024.12.039_b0530","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"issue":"11 November","key":"10.1016\/j.neuroscience.2024.12.039_b0535","article-title":"Quercetin exhibits potent antioxidant activity, restores motor and non-motor deficits induced by rotenone toxicity","volume":"16","author":"Madiha","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0540","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jpha.2021.09.009","article-title":"Antiviral, immunomodulatory, and anticoagulant effects of quercetin and its derivatives: potential role in prevention and management of COVID-19","volume":"12","author":"Manjunath","year":"2022","journal-title":"J. Pharm. Anal."},{"issue":"6","key":"10.1016\/j.neuroscience.2024.12.039_b0545","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1124\/mol.111.071290","article-title":"Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to alzheimer\u2019s disease","volume":"79","author":"Mart\u00edn-Moreno","year":"2011","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.039_b0550","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/plants7020030","article-title":"Flavonoid functions in plants and their interactions with other organisms","volume":"7","author":"Mathesius","year":"2018","journal-title":"Plants"},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.039_b0555","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bph.12944","article-title":"Are cannabidiol and \u0394 9 \u2010tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review","volume":"172","author":"McPartland","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuroscience.2024.12.039_b0560","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.nbd.2013.06.016","article-title":"Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors","volume":"59","author":"Mecha","year":"2013","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.neuroscience.2024.12.039_b0565","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB","volume":"26","author":"Moliner","year":"2023","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0570","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41398-020-01011-0","article-title":"N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo","volume":"10","author":"Morales-Garcia","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"16","key":"10.1016\/j.neuroscience.2024.12.039_b0575","doi-asserted-by":"crossref","first-page":"9328","DOI":"10.3390\/ijms23169328","article-title":"Antioxidant therapeutic strategies in neurodegenerative diseases","volume":"23","author":"Mor\u00e9n","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.039_b0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0060863","article-title":"Stimulation of the sigma-1 receptor by DHEA enhances synaptic efficacy and neurogenesis in the hippocampal dentate gyrus of olfactory bulbectomized mice","volume":"8","author":"Moriguchi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2024.12.039_b0585","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neuint.2015.09.005","article-title":"Modulation of BV-2 microglia functions by novel quercetin pivaloyl ester","volume":"90","author":"Mrvov\u00e1","year":"2015","journal-title":"Neurochem. Int."},{"issue":"327","key":"10.1016\/j.neuroscience.2024.12.039_b0590","article-title":"N,N-dimethyltryptamine reduces infarct size and improves functional recovery following transient focal brain ischemia in rats","volume":"2020","author":"Nardai","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuroscience.2024.12.039_b0595","first-page":"770","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","author":"Newman","year":"2020","journal-title":"J. Natl. Prod. American Chemical Society March 27"},{"issue":"29","key":"10.1016\/j.neuroscience.2024.12.039_b0600","doi-asserted-by":"crossref","first-page":"25337","DOI":"10.1021\/acsomega.2c02285","article-title":"Free radical chain reactions and polyunsaturated fatty acids in brain lipids","volume":"7","author":"Ng","year":"2022","journal-title":"ACS Omega"},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.039_b0605","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens","volume":"101","author":"Nichols","year":"2004","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.039_b0610","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"7","key":"10.1016\/j.neuroscience.2024.12.039_b0615","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002558","article-title":"Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways","volume":"3","author":"Nishimura","year":"2008","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.neuroscience.2024.12.039_b0620","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/bph.13497","article-title":"An update on PPAR activation by cannabinoids","volume":"173","author":"O\u2019Sullivan","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.039_b0625","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial","volume":"49","author":"Palhano-Fontes","year":"2019","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0630","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrn3379","article-title":"Neurotrophin regulation of neural circuit development and function","volume":"14","author":"Park","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuroscience.2024.12.039_b0635","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00482","article-title":"Cannabidiol as a promising strategy to treat and prevent movement disorders?","volume":"9","author":"Peres","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.039_b0640","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB 1 and CB 2 receptor pharmacology of three plant cannabinoids: \u0394 9 \u2010tetrahydrocannabinol, cannabidiol and \u0394 9 \u2010tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.neuroscience.2024.12.039_b0645","doi-asserted-by":"crossref","first-page":"8342","DOI":"10.1002\/jcp.27725","article-title":"Medical cannabis: a plurimillennial history of an evergreen","volume":"234","author":"Pisanti","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.neuroscience.2024.12.039_b0650","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.589588","article-title":"Network pharmacology-based and experimental identification of the effects of quercetin on alzheimer\u2019s disease","volume":"12","author":"Qi","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0655","doi-asserted-by":"crossref","DOI":"10.1186\/s10020-022-00497-2","article-title":"Central nervous system effects of 5-HT7 receptors: a potential target for neurodegenerative diseases","volume":"28","author":"Quintero-Villegas","year":"2022","journal-title":"Mol. Med."},{"issue":"1473","key":"10.1016\/j.neuroscience.2024.12.039_b0660","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1098\/rstb.2006.1894","article-title":"Neurotrophin-regulated signalling pathways","volume":"361","author":"Reichardt","year":"2006","journal-title":"Philos. Trans. R. Soc., B"},{"issue":"13","key":"10.1016\/j.neuroscience.2024.12.039_b0665","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.3390\/ijms20133177","article-title":"The anti-cancer effect of quercetin: molecular implications in cancer metabolism","volume":"20","author":"Reyes-Farias","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.039_b0670","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1590\/1516-4446-2019-0810","article-title":"Cannabidiol in Parkinson\u2019s disease","volume":"42","author":"Rieder","year":"2020","journal-title":"Brazilian J. Psychiatry"},{"key":"10.1016\/j.neuroscience.2024.12.039_b0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2021.102047","article-title":"The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination","volume":"69","author":"Robaina Cabrera","year":"2021","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"AUG","key":"10.1016\/j.neuroscience.2024.12.039_b0680","first-page":"1","article-title":"Neuronal sigma-1 receptors: signaling functions and protective roles in neurodegenerative diseases","volume":"13","author":"Ryskamp","year":"2019","journal-title":"Front. Neurosci."},{"issue":"22","key":"10.1016\/j.neuroscience.2024.12.039_b0685","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.3390\/molecules25225474","article-title":"An overview of Nrf2 signaling pathway and its role in inflammation","volume":"25","author":"Saha","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0690","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/JCP.0000000000000436","article-title":"Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression a SPECT study","volume":"36","author":"Sanches","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuroscience.2024.12.039_b0695","doi-asserted-by":"crossref","unstructured":"Sanghai, N., Tranmer, G.K., 2023. Biochemical and molecular pathways in neurodegenerative diseases: an integrated view. Cells. Multidisciplinary Digital Publishing Institute (MDPI) September 1, DOI: 10.3390\/cells12182318.","DOI":"10.3390\/cells12182318"},{"issue":"18","key":"10.1016\/j.neuroscience.2024.12.039_b0700","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.3390\/cells12182318","article-title":"Biochemical and molecular pathways in neurodegenerative diseases: an integrated view","volume":"12","author":"Sanghai","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.neuroscience.2024.12.039_b0705","article-title":"Classification, biosynthesis and chemical ecology. In Flavonoids - From Biosynthesis to Human Health","author":"Santos","year":"2017","journal-title":"INTECH"},{"issue":"40","key":"10.1016\/j.neuroscience.2024.12.039_b0710","doi-asserted-by":"crossref","first-page":"13513","DOI":"10.1523\/JNEUROSCI.1665-10.2010","article-title":"Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a \u03b2-arrestin2\/Src\/Akt signaling complex in vivo","volume":"30","author":"Schmid","year":"2010","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.neuroscience.2024.12.039_b0715","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115991","article-title":"An unbalanced synaptic transmission: cause or consequence of the amyloid oligomers neurotoxicity?","volume":"22","author":"Sciaccaluga","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2024.12.039_b0720","first-page":"35","article-title":"Aportes Para Un Debate Sobre La Regulaci\u00f3n de La Ayahuasca En El Uruguay","volume":"13","author":"Scuro","year":"2015","journal-title":"Antropolog\u00eda Social y Cultural Del Uruguay"},{"issue":"9","key":"10.1016\/j.neuroscience.2024.12.039_b0725","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/cns.12129","article-title":"Sigma-1 receptor knockout impairs neurogenesis in dentate gyrus of adult hippocampus via down-regulation of NMDA receptors","volume":"19","author":"Sha","year":"2013","journal-title":"CNS Neurosci. Ther."},{"issue":"9","key":"10.1016\/j.neuroscience.2024.12.039_b0730","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/aps.2013.59","article-title":"Quercetin protects rat dorsal root ganglion neurons against high glucose-induced injury in vitro through Nrf-2\/HO-1 activation and NF-\u039aB inhibition","volume":"34","author":"Shi","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.039_b0735","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3390\/pharmaceutics15030749","article-title":"Plant-derived bioactive compounds in the management of neurodegenerative disorders: challenges, future directions and molecular mechanisms involved in neuroprotection","volume":"15","author":"Shoaib","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neuroscience.2024.12.039_b0740","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2023\/8825358","article-title":"Emerging therapeutic potential of cannabidiol (CBD) in neurological disorders: a comprehensive review","volume":"2023","author":"Singh","year":"2023","journal-title":"Behav. Neurol."},{"issue":"8","key":"10.1016\/j.neuroscience.2024.12.039_b0745","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/ars.2017.7290","article-title":"The role of sirtuins in antioxidant and redox signaling","volume":"28","author":"Singh","year":"2018","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0750","doi-asserted-by":"crossref","first-page":"3","DOI":"10.31887\/DCNS.2013.15.1\/gsmith","article-title":"Aging and neuroplasticity","volume":"15","author":"Smith","year":"2013","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuroscience.2024.12.039_b0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110367","article-title":"PPAR\u03b3 receptors are involved in the effects of cannabidiol on orofacial dyskinesia and cognitive dysfunction induced by typical antipsychotic in mice","volume":"111","author":"Sonego","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2024.12.039_b0760","first-page":"121","article-title":"Human psychopharmacology of N,N-dimethyltryptamine","volume":"73","author":"Strassman","year":"1996","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.039_b0765","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neulet.2011.09.028","article-title":"Protective effects of quercetin against hydrogen peroxide-induced apoptosis in human neuronal SH-SY5Y cells","volume":"504","author":"Suematsu","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.039_b0770","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.foodchem.2007.11.053","article-title":"Flavonols (kaempeferol, quercetin, myricetin) contents of selected fruits, vegetables and medicinal plants","volume":"108","author":"Sultana","year":"2008","journal-title":"Food Chem."},{"issue":"SEP","key":"10.1016\/j.neuroscience.2024.12.039_b0775","first-page":"1","article-title":"The endogenous hallucinogen and trace amine N,N-dimethyltryptamine (DMT) displays potent protective effects against hypoxia via sigma-1 receptor activation in human primary IPSC-derived cortical neurons and microglia-like immune cells","volume":"10","author":"Szabo","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuroscience.2024.12.039_b0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108612","article-title":"N,N-dimethyltryptamine attenuates spreading depolarization and restrains neurodegeneration by sigma-1 receptor activation in the ischemic rat brain","volume":"192","author":"Szab\u00f3","year":"2021","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.039_b0785","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1124\/jpet.102.041970","article-title":"Nerve growth factor-induced neurite sprouting in PC12 cells involves \u03c3-1 receptors: implications for antidepressants","volume":"303","author":"Takebayashi","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"9","key":"10.1016\/j.neuroscience.2024.12.039_b0790","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.180138","article-title":"Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models","volume":"8","author":"Taoufik","year":"2018","journal-title":"Open Biol."},{"issue":"12","key":"10.1016\/j.neuroscience.2024.12.039_b0795","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209250","article-title":"Cholinesterase inhibitor rivastigmine enhances nerve growth factor-induced neurite outgrowth in PC12 cells via sigma-1 and sigma-2 receptors","volume":"13","author":"Terada","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0800","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1568007043482633","article-title":"5-HT7 receptors","volume":"3","author":"Thomas","year":"2004","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-024-53363-y","article-title":"Effects of DMT on mental health outcomes in healthy volunteers","volume":"14","author":"Timmermann","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0810","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4103\/1673-5374.286952","article-title":"Mechanisms of neuroplasticity and brain degeneration: strategies for protection during the aging process","volume":"16","author":"Toricelli","year":"2021","journal-title":"Neural Regen. Res."},{"issue":"38","key":"10.1016\/j.neuroscience.2024.12.039_b0815","doi-asserted-by":"crossref","first-page":"23512","DOI":"10.1074\/jbc.271.38.23512","article-title":"Protein kinase C \u03b4 activates the MEK-ERK pathway in a manner independent of ras and dependent on raf","volume":"271","author":"Ueda","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.neuroscience.2024.12.039_b0820","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1002\/ptr.8168","article-title":"Exploring the therapeutic potential of quercetin: a focus on its sirtuin\u2010mediated benefits","volume":"38","author":"Ungurianu","year":"2024","journal-title":"Phytother. Res."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0825","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"7","key":"10.1016\/j.neuroscience.2024.12.039_b0830","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1002\/ptr.6382","article-title":"Dietary quercetin supplements: assessment of online product informations and quantitation of quercetin in the products by high\u2010performance liquid chromatography","volume":"33","author":"Vida","year":"2019","journal-title":"Phytother. Res."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.039_b0835","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1523\/JNEUROSCI.23-04-01398.2003","article-title":"Nonpsychotropic cannabinoid receptors regulate microglial cell migration","volume":"23","author":"Walter","year":"2003","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.039_b0840","article-title":"A richer and more diverse future for microglia phenotypes","volume":"9","author":"Wang","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.neuroscience.2024.12.039_b0845","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuroscience.2022.06.036","article-title":"Cannabidiol alleviates the damage to dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinson\u2019s disease mice via regulating neuronal apoptosis and neuroinflammation","volume":"498","author":"Wang","year":"2022","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.neuroscience.2024.12.039_b0850","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/WNR.0000000000001783","article-title":"Quercitrin improved cognitive impairment through inhibiting inflammation induced by microglia in alzheimer\u2019s disease mice","volume":"33","author":"Wang","year":"2022","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.039_b0855","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph14020076","article-title":"Structure, function, and pharmaceutical ligands of 5-hydroxytryptamine 2b receptor","volume":"14","author":"Wang","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0860","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-022-00524-0","article-title":"Solving neurodegeneration: common mechanisms and strategies for new treatments","volume":"17","author":"Wareham","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"13","key":"10.1016\/j.neuroscience.2024.12.039_b0865","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.3390\/cells11132091","article-title":"Microglia phenotypes in aging and neurodegenerative diseases","volume":"11","author":"Wendimu","year":"2022","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.neuroscience.2024.12.039_b0870","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3390\/molecules24061123","article-title":"Antioxidant activities of quercetin and its complexes for medicinal application","volume":"24","author":"Xu","year":"2019","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.039_b0875","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/acsptsci.0c00194","article-title":"The subjective effects of psychedelics are necessary for their enduring therapeutic effects","volume":"4","author":"Yaden","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"11","key":"10.1016\/j.neuroscience.2024.12.039_b0880","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.3390\/cells9112346","article-title":"Prevention by dietary polyphenols (resveratrol, quercetin, apigenin) against 7-ketocholesterol-induced oxiapoptophagy in neuronal N2a cells: potential interest for the treatment of neurodegenerative and age-related diseases","volume":"9","author":"Yammine","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.039_b0885","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuroscience.2024.12.039_b0890","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8210578","article-title":"Effect of quercetin on pc12 alzheimer\u2019s disease cell model induced by A \u03b2 25-35 and its mechanism based on sirtuin1\/Nrf2\/HO-1 pathway","volume":"2020","author":"Yu","year":"2020","journal-title":"Biomed Res. Int."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.039_b0895","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-020-00224-z","article-title":"Targeting neuroplasticity in patients with neurodegenerative diseases using brain stimulation techniques","volume":"9","author":"Yuan","year":"2020","journal-title":"Transl Neurodegener"},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.039_b0900","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00213-020-05692-9","article-title":"Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial","volume":"238","author":"Zeifman","year":"2021","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.039_b0905","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3390\/ijms21020493","article-title":"Quercetin in animal models of alzheimer\u2019s disease: a systematic review of preclinical studies","volume":"21","author":"Zhang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2024.12.039_b0910","first-page":"283","author":"Zhang","year":"2011","journal-title":"Properties of Quercetin"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224007462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224007462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T21:58:58Z","timestamp":1738015138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452224007462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":178,"alternative-id":["S0306452224007462"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.12.039","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plant-derived compounds and neurodegenerative diseases: Different mechanisms of action with therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.12.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}